Davita INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Jason M. Hollar, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Barbara J Desoer, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Adam H Schechter, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Gregory J. Moore, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Dennis W Pullin, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Wendy Lee Schoppert, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Pamela M Arway, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Phyllis R Yale, a Director of Davita Inc., received 278 shares of common stock on August 15, 2026.
NYSE
Berkshire Hathaway Inc and 1 other reported changes in beneficial ownership of Davita Inc. common stock on July 31, 2026.
NYSE
Kathleen Alyce Waters, Chief Legal & Public Affairs Officer at DaVita Inc., sold 15,405 shares of common stock.
NYSE
DaVita Inc. CEO Javier Rodriguez sold 69,407 shares of common stock over two days in mid-June 2026.
NYSE
DaVita Inc. director Phyllis Yale reported a gift of 5,038 shares of common stock on May 26, 2026.
NYSE
Davita Inc. Director Dennis W. Pullin acquired 250 shares of common stock on May 15, 2026, increasing his direct beneficial ownership.
NYSE
DaVita Inc. Director Gregory J. Moore acquired 250 shares of common stock on May 15, 2026, as reported in a Form 4 filing.
NYSE
Davita Inc. Director Wendy Lee Schoppert acquired 250 shares of common stock on May 15, 2026, as reported in a Form 4 filing.
NYSE
Davita Inc. director Pamela Arway acquired 250 shares of common stock on May 15, 2026, as reported in a Form 4 filing.
NYSE
DaVita Inc. director Phyllis R. Yale acquired 250 shares of common stock on May 15, 2026.
NYSE
DaVita Inc. Director Barbara J. Desoer acquired 250 shares of common stock.
NYSE
Adam H. Schechter, a Director at DaVita Inc., reported the acquisition of 250 shares of common stock on May 15, 2026.
NYSE
DaVita Inc. director Jason M. Hollar acquired 250 shares of common stock on May 15, 2026, as reported in a Form 4 filing.
NYSE
DaVita Inc. reports insider transactions where Chief Compliance Officer James O. Hearty acquired and disposed of company stock, including the exercise of Stock Appreciation Rights.
NYSE
DaVita Inc. Chief Operating Officer David Paul Maughan reported the sale of common stock totaling over $3.5 million across two transactions on May 11th and 12th, 2026.
NYSE
DaVita Inc. CFO and Treasurer Joel Ackerman reported a sale of 51,471 shares of common stock on May 7, 2026, for an average price of $192.099 per share.
NYSE
DaVita Inc. Chief Compliance Officer James Hearty sold 2,184 shares of common stock via a pre-arranged trading plan.
NYSE
Berkshire Hathaway Inc. and Warren Buffett reported the sale of 1,220,376 shares of DaVita Inc. common stock.
NYSE
Davita Inc. Director Pamela M Arway acquired 332 shares of common stock on March 15, 2026, increasing her beneficial ownership to 26,695 shares.
NYSE
Davita Inc. Director Barbara J. Desoer acquired 332 shares of common stock on March 15, 2026, as part of a pre-arranged Rule 10b5-1 plan.
NYSE
DaVita Inc. Director Phyllis R. Yale acquired 332 shares of common stock on March 15, 2026, as part of a pre-arranged plan.
NYSE
DaVita Inc. CEO Javier Rodriguez reported the acquisition of 20,900 restricted stock units and 56,506 stock appreciation rights on March 15, 2026, aligning his interests with shareholders.
NYSE
DaVita Inc. Director Dennis W. Pullin reported the acquisition of 332 shares of common stock, increasing his direct beneficial ownership to 2,421 shares.